News Conference News AHA 2020 OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP Shelley Wood November 14, 2020
News Industry News CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI October 17, 2020
News Conference News TCT 2020 FFR Insights Before and After PCI: Fresh Food for Thought Caitlin E. Cox October 16, 2020
News Conference News TCT 2020 Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk Caitlin E. Cox October 15, 2020
Presentation TCT 2020 The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients Presenter: Roxana Mehran October 15, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients L.A. McKeown June 17, 2020
News Industry News CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial June 01, 2020